Effect of medical treatments in disseminated peritoneal leiomyomatosis: a case report

Abstract Disseminated peritoneal leiomyomatosis (DPL) is a rare gynecologic disease involving multifocal proliferation of myomas. The pathogenesis remains unclear. Although there is no standard treatment, medical therapies have attempted to suppress estrogen levels by using gonadotrophin-releasing hormone agonist and aromatase inhibitor (AI) therapy with differing degrees of success. Surgery is also an option in symptomatic patients, and in the event of partial or no response to medical treatments. We report a case of DPL in a young woman with a previous history of myomectomy. She was treated sequentially with ulipristal acetate and AI.

[1]  EMA suspends licence for ulipristal acetate for uterine fibroids , 2020, Drug and Therapeutics Bulletin.

[2]  J. Huirne,et al.  Ulipristal acetate vs gonadotropin‐releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short‐term results of a double‐blind randomized controlled trial , 2019, Acta obstetricia et gynecologica Scandinavica.

[3]  A. Murji,et al.  Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis. , 2019, Obstetrics and gynecology.

[4]  A. Agarossi,et al.  Leiomyomatosis peritonealis disseminata: A case report of recurrent presentation and literature review , 2018, International journal of surgery case reports.

[5]  I. Lete,et al.  Parasitic leiomyomas: a systematic review. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[6]  M. Bongers,et al.  Parasitic myoma after laparoscopic morcellation: a systematic review of the literature , 2016, BJOG : an international journal of obstetrics and gynaecology.

[7]  J. Verguts,et al.  Symptom relief of leiomyomatosis peritonealis disseminata with ulipristal acetate , 2013, Gynecological Surgery.

[8]  I. Osterloh,et al.  Ulipristal acetate versus leuprolide acetate for uterine fibroids. , 2012, The New England journal of medicine.

[9]  M. Canis,et al.  "Iatrogenic" parasitic myomas: unusual late complication of laparoscopic morcellation procedures. , 2010, Journal of minimally invasive gynecology.

[10]  T. Takeda,et al.  Successful Management of a Leiomyomatosis Peritonealis Disseminata With an Aromatase Inhibitor , 2008, Obstetrics and gynecology.

[11]  N. Vavatsi-Christaki,et al.  The Effect of Anastrazole on Symptomatic Uterine Leiomyomata , 2007, Obstetrics and Gynecology.

[12]  M. Shozu,et al.  Aromatase and leiomyoma of the uterus. , 2004, Seminars in reproductive medicine.

[13]  P. Kamali,et al.  Leiomyomatosis peritonealis disseminata associated with endometriosis: a case report and literature review. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[14]  A. Peale,et al.  Multiple peritoneal leiomyomas associated with a granulosa-cell tumor of the ovary. , 1952, American journal of obstetrics and gynecology.